Prostacyclin counteracts the increase in capillary permeability induced by tumour necrosis factor-alpha.
OBJECTIVE
To analyse how prostacyclin interferes with the short-term local circulatory effects of tumour necrosis factor-alpha (TNF alpha) in a skeletal muscle.


METHODS
An autoperfused sympathectomised cat gastrocnemius muscle enclosed in a plethysmograph.


METHODS
Arterial blood flow, total and segmental vascular resistances (large-bore arterial vessels, arterioles and veins), hydrostatic capillary pressure, tissue volume and capillary filtration coefficient were followed during local intra-arterial infusion of TNF alpha at various rates (2.5, 5.0 and 7.5 micrograms/kg per min) and during intra-arterial infusion of prostacyclin simultaneously with the highest dose of TNF alpha. The capillary filtration coefficient reflects the capillary surface for fluid exchange.


RESULTS
Arterial infusion of TNFx had no influence on vascular resistance up to 5.0 micrograms/kg per min but induced vasodilation at 7.5 micrograms/kg per min. No effects on the recorded hydrostatic capillary pressure were observed. The capillary filtration coefficient and the capillary filtration increased with the infusion rate of TNF alpha, the former by 55%. Simultaneous arterial infusion of prostacyclin (350 ng/kg per min) caused further vasodilation and an increase in hydrostatic capillary pressure and completely restored the capillary filtration coefficient to control. The TNF alpha-induced filtration was partly restored.


CONCLUSIONS
The local circulatory effect of TNF alpha is small apart from a graded increase in the capillary filtration coefficient, most likely reflecting an increase in the capillary permeability. The prostacyclin-induced decrease in capillary filtration coefficient most likely reflects a restoration of capillary permeability. The TNF alpha-induced transcapillary filtration is not fully reduced by prostacyclin due to a simultaneous increase in hydrostatic capillary pressure.
Jahr
J
J
Department of Physiology and Neuroscience, University of Lund, Sweden.
Grände
P O
PO
D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects*; D002415:Cats; D011464:Epoprostenol / Q000502:physiology*; D006439:Hemodynamics / Q000187:drug effects; D007261:Infusions, Intra-Arterial; D008833:Microcirculation / Q000187:drug effects; D018482:Muscle, Skeletal / Q000098:blood supply*; D013562:Sympathectomy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000502:physiology*
D014409:Tumor Necrosis Factor-alpha; D011464:Epoprostenol